Valuation: Baxter International Inc.

Market Cap 11.4B 9.99B 9.23B 8.49B 16.03B 1,099B 16.28B 110B 43.29B 538B 42.8B 41.87B 1,853B P/E 2026 *
50.9x
P/E 2027 * 28x
Enterprise Value 17.74B 15.55B 14.37B 13.22B 24.94B 1,711B 25.34B 172B 67.37B 837B 66.61B 65.16B 2,884B EV / Sales 2026 *
1.56x
EV / Sales 2027 * 1.5x
Free-Float
75.3%
Yield 2026 *
0.18%
Yield 2027 * 0.18%
1 day+0.43%
1 week+1.61%
Current month+3.89%
1 month+12.67%
3 months+19.79%
6 months+12.38%
Current year+15.91%
1 week 21.82
Extreme 21.815
23.71
1 month 19.42
Extreme 19.42
23.71
Current year 15.73
Extreme 15.73
23.71
1 year 15.73
Extreme 15.73
29.35
3 years 15.73
Extreme 15.73
49.29
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 01/08/2025
Director of Finance/CFO 52 16/03/2026
Chief Tech/Sci/R&D Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 66 18/02/2019
Director/Board Member 65 01/01/2019
Director/Board Member 69 15/02/2021
Date Insider Type Main position Quantity % Market Cap.
02/06/26 Tax

President, Adv. Surgery

-153 0.0000%
02/06/26 Tax

President, CCS

-321 0.0001%
01/06/26 Free

Chief Financial Officer

13,426 0.0026%
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%+1.61%-19.07%-54.39% 11.4B
-0.13%+13.84%-18.61%-11.39% 177B
-0.75%+4.05%-8.02%-7.25% 107B
-0.27%+0.15%+3.43%+57.18% 59.14B
+0.93%-0.47%+41.62%+62.05% 51.89B
-0.80%+1.85%-12.49%-42.07% 42.57B
+1.59%+1.09% - - 32.88B
-1.24%+0.90%-11.00%-42.73% 29.21B
+1.37%-0.12%+70.04%-5.32% 24.89B
-0.90%+1.68%-4.67%-8.55% 20.9B
Average +0.02%+0.02%+4.58%-5.83% 55.66B
Weighted average by Cap. -0.15%+2.81%-2.31%-0.30%

Financials

2026 *2027 *
Net sales 11.35B 9.95B 9.2B 8.46B 15.96B 1,095B 16.22B 110B 43.11B 536B 42.63B 41.7B 1,846B 11.58B 10.15B 9.38B 8.63B 16.29B 1,117B 16.55B 112B 43.99B 547B 43.49B 42.55B 1,883B
Net income 218M 192M 177M 163M 307M 21.07B 312M 2.12B 830M 10.31B 820M 803M 35.52B 397M 348M 322M 296M 559M 38.31B 567M 3.85B 1.51B 18.74B 1.49B 1.46B 64.58B
Net Debt 6.34B 5.56B 5.14B 4.73B 8.92B 612B 9.06B 61.44B 24.08B 299B 23.81B 23.29B 1,031B 5.95B 5.21B 4.82B 4.43B 8.36B 574B 8.5B 57.63B 22.59B 281B 22.34B 21.85B 967B
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
21/07/26 $22.17 +0.45% 381,003
20/07/26 $22.07 -2.39% 4,980,251
17/07/26 $22.61 -3.17% 6,546,823
16/07/26 $23.35 +5.42% 6,942,196
15/07/26 $22.15 +1.61% 5,022,272
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
22.07USD
Average target price
21.95USD
Spread / Average Target
-0.52%

Quarterly revenue - Rate of surprise